STAT3 and neoplasm: Additionally, IL-6 binds to its receptor IL-6R to regulating Janus kinase (JAK)/STAT3 signaling pathways, then stimulating the proliferation of tumor cells and the stemness of breast cancer stem cells (CSCs) [10].